Spago Nanomedical Interim Report January-March 2026
(PR-inside.com) LUND, SE / ACCESS Newswire / May 7, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) JANUARY - MARCH IN BRIEF Net sales for the quarter amounted to KSEK 22 (KSEK 338) The loss for the quarter amounted to KSEK -6,798 (KSEK -7,435) Operating expenses for the quarter amounted to KSEK -7,967 (KSEK -8,964)…
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


